Particle Design
Building LNPs around desired properties from the beginning.
Next-generation lipid nanoparticles
A frontier biotechnology company developing a differentiated approach to particle design.
Learn moreThe platform
A differentiated way to build particles.
Rather than treating formulation as an empirical search problem, BIZON is developing a framework for designing particles around the properties we want them to have. Our work connects process development, particle architecture, and biological performance.
01
Inputs
02
Process
03
Architecture
04
Biology
Structural Control
Exploring how process innovations can influence LNP architecture.
Delivery Biology
Mapping the relationship between LNP architecture and complex biological systems.
Translational Readiness
Developing with real-world therapeutic applications in mind, and scalable by design.
The Herd
The people walking into the hard problems.
BIZON Labs is led by co-founders Peter Sagmeister, Aniket Udepurkar, and Cedric Devos, bringing together experience across formulation, self-assembly, translational science, company formation, and biotechnology operations, with support and mentorship from a broader group of scientific, clinical, and company-building advisors.
Why this matters
RNA medicines are advancing.
Delivery systems have not kept pace.
Lipid nanoparticles are the leading non-viral delivery system for RNA and DNA medicines. Yet the field still depends on particles that are difficult to control, hard to tune, and often discovered through extensive empirical screening.
BIZON Labs is built around a simple belief: the next generation of LNPs should be designed more intentionally from the beginning.
The name BIZON is a nod to bison, which are known for turning into a storm and moving through it rather than away from it. We take the same posture in science: walking directly toward hard delivery challenges with focus, patience, and conviction.
The belief
Particles should not only be screened into existence. They should be built around the properties we want them to have.
Scientific track record
The full-time team behind BIZON Labs has authored 60+ publications with 1,500+ citations across public research profiles.
News / Announcements
Updates from BIZON Labs.
Selected company and science updates as we continue building the platform.
BIZON Labs public site is live
We are beginning to share more about our approach to next-generation lipid nanoparticle design.
Platform overview available
A lecture-style overview introduces the scientific thinking behind the company.
Scientific and strategic conversations
We are speaking with collaborators, investors, mentors, and partners aligned with formulation, process development, and delivery biology.
Invitation
For scientific, partnership, investment, and career conversations.
We welcome conversations with people interested in the future of lipid nanoparticle technology.
Interested in joining the herd?
office@bizonlabs.com